» Authors » Banwari Agarwal

Banwari Agarwal

Explore the profile of Banwari Agarwal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 1119
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sangam A, Agarwal B, Saha R
Aliment Pharmacol Ther . 2024 Oct; 60(11-12):1625-1626. PMID: 39468937
No abstract available.
2.
Burke L, Bernal W, Pirani T, Agarwal B, Jalan R, Ryan J, et al.
J Hepatol . 2024 Oct; PMID: 39362282
Background & Aims: Therapeutic plasma exchange (PEX) has emerged as a potential treatment option for patients with acute liver failure (ALF). The effect of PEX on survival outcomes outside of...
3.
Kumar R, Lin S, Mehta G, Mesquita M, Calvao J, Sheikh M, et al.
Aliment Pharmacol Ther . 2024 Aug; 60(7):907-920. PMID: 39091108
Background: Apart from direct portal pressure reduction, non-selective beta-blockers (NSBB) modulate inflammatory response, which could be beneficial in patients with acute decompensation (AD). We therefore aimed to evaluate the effect...
4.
Kanitkar T, Bakewell N, Dissanayake O, Symonds M, Rimmer S, Adlakha A, et al.
J Intensive Care Med . 2024 Apr; 39(9):883-894. PMID: 38563646
Background: Despite widespread use of combination antiretroviral therapy, people with HIV (PWH) continue to have an increased risk of admission to and mortality in the intensive care unit (ICU). Mortality...
5.
Saeidinejad M, Elshabrawi A, Sriphoosanaphan S, Andreola F, Mehta G, Agarwal B, et al.
Semin Liver Dis . 2023 Dec; 43(4):429-445. PMID: 38101419
Acute-on-chronic liver failure (ACLF), a clinical syndrome that can develop at any stage in the progression of cirrhotic liver disease, is characterized by an acute decompensation in liver function with...
6.
Chowdary P, Agarwal B, Peralta M, Bhagani S, Lee S, Goldring J, et al.
J Clin Med . 2023 Sep; 12(18). PMID: 37762789
Acute lung injury in COVID-19 results in diffuse alveolar damage with disruption of the alveolar-capillary barrier, coagulation activation, alveolar fibrin deposition and pulmonary capillary thrombi. Nebulized recombinant tissue plasminogen activator...
7.
Kanitkar T, Dissanayake O, Bakewell N, Symonds M, Rimmer S, Adlakha A, et al.
AIDS . 2023 Aug; 37(14):2169-2177. PMID: 37605448
Objective: Limited data suggest intensive care unit (ICU) outcomes have improved in people with HIV (PWH). We describe trends in in-ICU/in-hospital mortality among PWH following admission to ICU in a...
8.
Agarwal B, Canizares R, Saliba F, Ballester M, Tomescu D, Martin D, et al.
J Hepatol . 2023 Jun; 79(1):79-92. PMID: 37268222
Background & Aims: Acute-on-chronic liver failure (ACLF) is characterized by severe systemic inflammation, multi-organ failure and high mortality rates. Its treatment is an urgent unmet need. DIALIVE is a novel...
9.
Bakewell N, Kanitkar T, Dissanayake O, Symonds M, Rimmer S, Adlakha A, et al.
HIV Med . 2022 Nov; 23(11):1163-1172. PMID: 36404292
Objectives: Despite improvements in survival of people with HIV admitted to the intensive care unit (ICU), late diagnosis continues to contribute to in-ICU mortality. We quantify the population attributable fraction...
10.
Artzner T, Conti S, Cortesi P, Sacleux S, Fernandez J, Morelli M, et al.
Liver Transpl . 2022 May; 28(9):1429-1440. PMID: 35544360
There is growing evidence that liver transplantation (LT) is the most effective treatment for acute-on-chronic liver failure grade-3 (ACLF-3). This study examines whether and how this evidence translates into practice...